Viva Biotech (01873.HK) provides one-stop services ranging from early-stage Structure-Based Drug R&D to commercial drug delivery to global biopharmaceutical innovators.

 

Since establishment in 2008, Viva Biotech has continued to enhance technology and service capabilities and promote industry chain integration to build the world leading one-stop platform from SBDD to commercial drug delivery. In 2021, Viva Biotech completed to conduct vertical integration and expansion into CDMO (Contract R&D and Production Organization) business, and established a comprehensive one-stop drug services platform.

 

Recently, Viva Biotech has launched the new website and Logo, and its subordinate departments - VBI also launched a new Logo. The new website expresses Viva’s corporate vision, mission and values, and introduces the services and core technology of Viva Biotech.

​

​

​

​

(The New Logo of Viva and VBI)

 

Viva Biotech will adhere to the values of Innovation, Integrity and Professionalism, Customer Success, and Win-win Cooperation. We are committed to becoming a long-term partner of global innovative biotech companies, insisting that to be Innovation-Driven, to be Empowered by Cutting-Edge Technology, to Strive for Excellence, and to benefit patients all around the world.

​

​